"We have a robust balance sheet; we ended the year last year with over $200,000 million in cash with no debt; we are hiring people, particularly on the cancer side who have significant experience in commercializing oncology products, including, most recently, Alan Colowick who came to us indirectly from Amgen of Aranesp fame. So the company is maturing, and this is the year, ‘07, in which we will fully complete our transition from a science company to a product company. By this time next year we'll have four products in the clinic: the inhibitor drug, the telomerase vaccine, the activator drug, and the world's first embryonic stem cell therapy for acute spinal cord injury."
Reg. the figure above for cash does he mean
$200,000 million as $200,000,000 or $200,000 or $200,000,000,000
Or $200,000 and a million
Puzzled by the wording.
mj |
